Moneycontrol PRO

you are here: HomeNewsBusinessStocksSell Ranbaxy; target Rs 270: Ranjit Kapadia

SHOW NAMES

Trending Topics

Sensex Live RPP Infra Projects Shares Zydus Lifesciences Shares Amanta Healthcare IPO Allotment LIVE GST on Health Insurance

business

Sell Ranbaxy; target Rs 270: Ranjit Kapadia

Ranjit Kapadia, pharma analyst of Centrum Broking suggests selling Ranbaxy Laboratories with a target Rs 270.

first published: Mar 14, 2014 03:53 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347